Review: taking Flexeril and Tapazole together


Summary

Drug interactions are reported among people who take Flexeril and Tapazole together. This review analyzes the effectiveness and drug interactions between Flexeril and Tapazole. It is created by eHealthMe based on reports of 34 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Flexeril

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. (latest outcomes from Flexeril 24,055 users)

Tapazole

Tapazole has active ingredients of methimazole. It is often used in hyperthyroidism. (latest outcomes from Tapazole 1,296 users)

On Sep, 15, 2016

34 people who take Flexeril, Tapazole are studied.


Number of reports submitted per year:

Flexeril and Tapazole drug interactions.

Drug effectiveness over time:

Flexeril:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Tapazole:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Flexeril:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)
Tapazole:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Flexeril:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Tapazole:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

1 - 6 months:
  • cholecystitis chronic
  • gallbladder injury
  • injury
  • pain
  • anxiety
  • deep vein thrombosis
  • depression
  • dizziness
  • dyspnoea
  • emotional distress
5 - 10 years:
  • anxiety
  • deep vein thrombosis
  • depression
  • dizziness
  • dyspnoea
  • emotional distress
  • fatigue
  • gastrointestinal haemorrhage
  • heart injury
  • musculoskeletal chest pain
not specified:
  • headache
  • dizziness
  • weight decreased
  • weight increased
  • pain
  • asthenia
  • depression
  • fatigue
  • nausea
  • oropharyngeal pain

Most common drug interactions by gender *:

female:
  • dizziness
  • headache
  • pain
  • anxiety
  • arthritis
  • chills
  • depression
  • fall
  • fatigue
  • weight increased
male:
  • dry mouth
  • weight decreased
  • abdominal pain
  • abdominal pain upper
  • acute myocardial infarction
  • asthenia
  • atelectasis
  • atrial fibrillation
  • atrial septal defect
  • atrioventricular block first degree

Most common drug interactions by age *:

20-29:
  • aphasia
  • cerebral artery embolism
  • cerebral haemorrhage
  • confusional state
  • haemorrhagic stroke
  • headache
  • intracranial venous sinus thrombosis
  • balance disorder
  • blood pressure increased
  • cholecystitis chronic
30-39:
  • acne
  • ankylosing spondylitis
  • arthritis
  • fatigue
  • injection site haematoma
  • pain
  • rash erythematous
40-49:
  • abdominal pain upper
  • malaise
  • abdominal pain
  • acute myocardial infarction
  • asthenia
  • atelectasis
  • atrial fibrillation
  • atrial septal defect
  • atrioventricular block first degree
  • back pain
50-59:
  • anxiety
  • depression
  • pain
  • ankle fracture
  • arthritis
  • asthenia
  • attention deficit/hyperactivity disorder
  • back disorder
  • basedow's disease
  • bipolar disorder
60+:
  • drug ineffective
  • somnolence
  • weight decreased
  • gastrointestinal haemorrhage
  • adenocarcinoma
  • ascites
  • confusional state
  • dehydration
  • drug hypersensitivity
  • dry mouth

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Flexeril and Tapazole?

Can you answer these questions?

More questions for: Flexeril, Tapazole

You may be interested in these reviews

More reviews for: Flexeril, Tapazole

On eHealthMe, Flexeril (cyclobenzaprine hydrochloride) is often used to treat muscle spasms. Tapazole (methimazole) is often used to treat hyperthyroidism. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.